The outlook of companies tied to the drug's past presents a intricate investment scenario . While the initial boom generated substantial gains, generic competition have significantly diminished revenue. https://mypresspage.com/story6738629/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-opportunity